Search research articles
Contact Us
Filters
Showing results (61-70 of 476) with videos related to
Page
of 48
Sort By:
Bioinformatics (Oxford, England)
|
December 25, 2003
Adjustment of systematic microarray data biases
Monica Benito, Joel Parker, Quan Du, et al.
Oncogene
|
March 10, 2015
Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
J Knezevic, A D Pfefferle, I Petrovic, et al.
BMC Genomics
|
June 4, 2014
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
Wei Zhao, Xiaping He, Katherine A Hoadley, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis
Jian Jiang, Carol E Parker, Katherine A Hoadley, et al.
Breast Cancer Research and Treatment
|
June 26, 2015
Race-associated biological differences among Luminal A breast tumors
Monica D'Arcy, Jodie Fleming, Whitney R Robinson, et al.
Genome Medicine
|
December 1, 2018
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer
Maki Tanioka, Kevin R Mott, Daniel P Hollern, et al.
Genome Biology
|
February 22, 2020
A framework for transcriptome-wide association studies in breast cancer in diverse study populations
Arjun Bhattacharya, Montserrat García-Closas, Andrew F Olshan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 26, 2017
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
Hawazin Faruki, Gregory M Mayhew, Jonathan S Serody, et al.
Endocrine-Related Cancer
|
September 22, 2001
Microarrays in primary breast cancer--lessons from chemotherapy studies
P E Lønning, T Sørlie, C M Perou, et al.
Breast Cancer Research and Treatment
|
March 5, 2011
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Stefan Glück, Jeffrey S Ross, Melanie Royce, et al.
Page
of 48
Search research articles
Search
Showing results (61-70 of 476) with videos related to
Sort By:
Page
of 48
Bioinformatics (Oxford, England)
|
December 25, 2003
Adjustment of systematic microarray data biases
Monica Benito, Joel Parker, Quan Du, et al.
Oncogene
|
March 10, 2015
Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
J Knezevic, A D Pfefferle, I Petrovic, et al.
BMC Genomics
|
June 4, 2014
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
Wei Zhao, Xiaping He, Katherine A Hoadley, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis
Jian Jiang, Carol E Parker, Katherine A Hoadley, et al.
Breast Cancer Research and Treatment
|
June 26, 2015
Race-associated biological differences among Luminal A breast tumors
Monica D'Arcy, Jodie Fleming, Whitney R Robinson, et al.
Genome Medicine
|
December 1, 2018
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer
Maki Tanioka, Kevin R Mott, Daniel P Hollern, et al.
Genome Biology
|
February 22, 2020
A framework for transcriptome-wide association studies in breast cancer in diverse study populations
Arjun Bhattacharya, Montserrat García-Closas, Andrew F Olshan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 26, 2017
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
Hawazin Faruki, Gregory M Mayhew, Jonathan S Serody, et al.
Endocrine-Related Cancer
|
September 22, 2001
Microarrays in primary breast cancer--lessons from chemotherapy studies
P E Lønning, T Sørlie, C M Perou, et al.
Breast Cancer Research and Treatment
|
March 5, 2011
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Stefan Glück, Jeffrey S Ross, Melanie Royce, et al.
Page
of 48